DHFR and colorectal carcinoma: Findings from the study highlighted that Dvl-3 might have a functional role in the acquisition of Methotrexate (MTX, an inhibitor of the dihydrofolate reductase (DHFR) enzyme) resistance and stem cell-like properties in CRC cell lines, although the mechanistic details of the resistance still remain unknown.